Invited paperSubstituent effect of side chains on the photochemical behavior of a new generation 1,4-dihydropyridine: Lercanidipine
-
Add time:08/30/2019 Source:sciencedirect.com
Lercanidipine (LERCA) is a third generation antihypertensive drug belonging to the 1,4-dihydropyridine’s family, which has been reported to induce photoallergic and/or phototoxic effects in patients with long term treatment. The electronic nature of substituents on the 4-aryl moiety bonded to the 1,4-dihydropyridine ring has been described to strongly affect the photophysical and photochemical behavior of this family of compounds, which displays a typical absorption band around 360 nm. LERCA undergoes photodegradation after excitation, with a first order kinetic, in significant competition to the radiative path. The photodegradation quantum yields for LERCA are higher than for its homologue nimodipine (NIMO), thus indicating that the substituents on the 1,4-dihydropyridinic ring also affect their photophysical and photochemical properties. The media where the photodegradation takes place impacts on the product profile, in a homogeneous one the photoproducts obtained appear to be more polar than those obtained for a micro-heterogeneous one (micelles or bilayers mimicking biological media).
We also recommend Trading Suppliers and Manufacturers of Lercanidipine hydrochloride (cas 132866-11-6). Pls Click Website Link as below: cas 132866-11-6 suppliers
Prev:pH-0064ependent gradient release microspheres of Lercanidipine hydrochloride (cas 132866-11-6): in vitro and in vivo evaluation
Next:Original ArticleDetermination of lercanidipine in human plasma by an improved UPLC–MS/MS method for a bioequivalence study☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- A novel nanoproliposomes of lercanidipine: Development, in vitro and preclinical studies to support its effectiveness in hypertension therapy09/02/2019
- Research paperDevelopment of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation09/01/2019
- Original ArticleDetermination of lercanidipine in human plasma by an improved UPLC–MS/MS method for a bioequivalence study☆08/31/2019
- pH-0064ependent gradient release microspheres of Lercanidipine hydrochloride (cas 132866-11-6): in vitro and in vivo evaluation08/29/2019
- Oral self emulsifying powder of Lercanidipine hydrochloride (cas 132866-11-6): Formulation and evaluation08/28/2019
- Research paperSolid self-emulsified nanostructures of Lercanidipine hydrochloride (cas 132866-11-6): A potential approach to improve the fraction of the dose absorbed08/27/2019
- Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of Lercanidipine hydrochloride (cas 132866-11-6)08/26/2019
- Original ArticleApplication of planar chromatography for estimation of Lercanidipine hydrochloride (cas 132866-11-6) in dosage form08/25/2019
-
Health and Chemical more >


